MentalHealthDaily

Prolonged Antidepressant Effect of Ketamine: NMDA Receptors & Lateral Habenula “Trapping”

by GLOOM

Ketamine causes rapid and sustained antidepressant effects that last longer than its presence in the body. This is due to ketamine getting trapped and accumulating in NMDA receptors, causing prolonged neural inhibition. Manipulating brain activity can shorten or extend ketamine’s effects. Highlights: Ketamine continues blocking NMDA receptors for 24 hours despite rapid elimination from plasma …

NLRP3 Inflammasome & Depression: A Target for Antidepressant Development?

by GLOOM

The NLRP3 inflammasome stands at the crossroads of immune response and mental health, playing a pivotal role in the inflammatory processes implicated in depression. Researchers are exploring the intricate relationship between NLRP3 activation and depressive disorders, highlighting the potential for innovative treatments targeting this complex molecular pathway. Highlights: NLRP3 Inflammasome Activation: NLRP3, a component of …

Elevated Mitochondrial DNA (mtDNA) Levels Linked to Depression (Possible Diagnostic Biomarker)

by GLOOM

New research reveals that individuals with depression exhibit significantly higher levels of mitochondrial DNA (mtDNA) compared to healthy individuals. This suggests mtDNA could serve as a promising biomarker to improve depression diagnosis and treatment outcomes. Key facts: Meta-analysis of 12 studies with 1400 participants shows elevated mtDNA levels in blood and skin cells of depressed …

Mycobacterium vaccae Vaccine: A Novel Soil Bacteria-Based Treatment for Anxiety & Stress Disorders

by GLOOM

Stress can induce anxiety and depression, which appears to be mediated in part by stress-induced neuroinflammatory processes. The immunoregulatory bacterium Mycobacterium vaccae (M. vaccae) has anti-inflammatory and stress-resilient effects, but its impact on the brain is unclear. A study discovered that M. vaccae immunization: induces anti-inflammatory and immunoregulatory processes in the hippocampus, blocks stress-induced neuroinflammation …

Allopregnanolone Agonists for Depression: Brexanolone & Zuranolone in Focus (2023)

by GLOOM

Allopregnanolone agonists represent a promising new class of medications for treating depressive disorders. Evidence suggests that allopregnanolone agonists exhibit rapid-onset of antidepressant action – particularly in women with postpartum depression (PPD). Key facts: Allopregnanolone is a neurosteroid that acts as a positive allosteric modulator of GABAA receptors and is decreased in depressive disorders. The allopregnanolone …

Top 12 Antidepressant Nutrients & Foods for Depression Treatment

by GLOOM

Depression is a growing public health concern, but nutrition may offer a pathway for prevention and treatment. A new research study identified the most nutrient-dense foods for brain health to inform dietary recommendations. Key Facts: 12 nutrients have evidence supporting a role in preventing and treating depression, including omega-3s, B vitamins, minerals like magnesium, and …

Eye Tracking Technology for Rapid Depression Diagnosis in Young Adults

by GLOOM

Researchers have proposed a novel eye tracking method to rapidly screen for depression risk in young adults. This intelligent approach analyzes emotional perception deficits through objective eye movement biomarkers. Initial findings suggest promise for large-scale, low-cost depression screening without specialized doctors. Key Facts: The “eye movement emotional perception evaluation paradigm” extracts digital biomarkers related to …